Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Blunt

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Biomedicines|June 26, 2025
NK Cells in Health and DiseaseMatthew D Blunt
Blood|March 21, 2024
Targeting CD161 in B-cell malignanciesMatthew D Blunt
International Journal of Immunogenetics|November 23, 2019
Activating killer cell immunoglobulin-like receptors: Detection, function and therapeutic useMatthew D Blunt, Salim I Khakoo
Current Opinion in Pharmacology|April 10, 2012
Targeting PI3K isoforms and SHIP in the immune system: new therapeutics for inflammation and leukemiaMatthew D Blunt, Stephen G Ward
Blood|December 31, 2016
Releasing the brakes on BTK-targeting miRNAMatthew D Blunt, Andrew J Steele
Frontiers in Immunology|August 10, 2012
Pharmacological targeting of phosphoinositide lipid kinases and phosphatases in the immune system: success, disappointment, and new opportunitiesMatthew D Blunt, Stephen G Ward
Immunotherapy Advances|January 15, 2024
Harnessing natural killer cell effector function against cancerMatthew D Blunt, Salim I Khakoo
Leukemia Research Reports|October 27, 2015
Pharmacological targeting of PI3K isoforms as a therapeutic strategy in chronic lymphocytic leukaemiaMatthew D Blunt, Andrew J Steele
Blood|June 25, 2016
To BH3 profile or not to BH3 profileMatthew D Blunt, Andrew J Steele
Journal of Translational Genetics and Genomics|December 10, 2021
The role of NK cells in oncolytic viral therapy: a focus on hepatocellular carcinomaFrazer Warricker, Salim I Khakoo, Matthew D Blunt
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Biomedicines|June 26, 2025
NK Cells in Health and DiseaseMatthew D Blunt
Blood|March 21, 2024
Targeting CD161 in B-cell malignanciesMatthew D Blunt
International Journal of Immunogenetics|November 23, 2019
Activating killer cell immunoglobulin-like receptors: Detection, function and therapeutic useMatthew D Blunt, Salim I Khakoo
Current Opinion in Pharmacology|April 10, 2012
Targeting PI3K isoforms and SHIP in the immune system: new therapeutics for inflammation and leukemiaMatthew D Blunt, Stephen G Ward
Blood|December 31, 2016
Releasing the brakes on BTK-targeting miRNAMatthew D Blunt, Andrew J Steele
Frontiers in Immunology|August 10, 2012
Pharmacological targeting of phosphoinositide lipid kinases and phosphatases in the immune system: success, disappointment, and new opportunitiesMatthew D Blunt, Stephen G Ward
Immunotherapy Advances|January 15, 2024
Harnessing natural killer cell effector function against cancerMatthew D Blunt, Salim I Khakoo
Leukemia Research Reports|October 27, 2015
Pharmacological targeting of PI3K isoforms as a therapeutic strategy in chronic lymphocytic leukaemiaMatthew D Blunt, Andrew J Steele
Blood|June 25, 2016
To BH3 profile or not to BH3 profileMatthew D Blunt, Andrew J Steele
Journal of Translational Genetics and Genomics|December 10, 2021
The role of NK cells in oncolytic viral therapy: a focus on hepatocellular carcinomaFrazer Warricker, Salim I Khakoo, Matthew D Blunt
Pageof 4